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The ability to differentiate viable from non-viable myocardium is clinically im-
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Purpose: To evaluate the potential of prospective electrocardiography (ECG)-
gated 64-slice multidetector computed tomography (MDCT) for evaluation of
myocardial enhancement, infarct size, and stent patency after percutaneous
coronary intervention (PCI) with stenting in patients with myocardial infarction.
Materials and Methods: Seventeen patients who were admitted with acute
myocardial infarction were examined with prospective ECG-gated 64-slice
cardiac MDCT and magnetic resonance (MR) imaging after reperfusion using PCI
with stenting. Cardiac MDCT was performed with two different phases: arterial
and delayed phases. We evaluated the stent patency on the arterial phase, and
nonviable myocardium on the delayed phase of computed tomography (CT)
image, and they were compared with the results from the delayed MR images.
Results: Total mean radiation dose was 7.7 ± 0.5 mSv on the two phases of CT
images. All patients except one showed good patency of the stent at the culprit
lesion on the arterial phase CT images. All patients had hyperenhanced area on the
delayed phase CT images, which correlated well with those on the delayed phase
MR images, with a mean difference of 1.6% (20 ± 10% vs. 22  ± 10%, r = 0.935,
p = 0.10). Delayed MR images had a better contrast-to-noise ratio (CNR) than
delayed CT images (27.1 ± 17.8% vs. 4.3 ± 2.1%, p < 0.001). Conclusion:
Prospective ECG-gated 64-slice MDCT provides the potential to evaluate
myocardial viability on delayed phase as well as for stent patency on arterial phase
with an acceptable radiation dose after PCI with stenting in patients with myo-
cardial infarction.
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INTRODUCTION
portant for determining the therapeutic management of
patients with coronary artery disease and also for predict-
ing functional recovery in the culprit arterial territory.1,2 Over
the past several years, delayed contrast-enhanced magnetic
resonance (MR) imaging has been regarded as a clinically
validated tool in the assessment of myocardial viability
and infarct morphology.3,4 However, MR imaging requires
a long acquisition time and has limitations in patients with
implantable cardiac defibrillators and biventricular pacing
devices.2 Moreover, there are difficulties in evaluating
coronary artery disease or stent patency with MRI.
The recent advent of multidetector computed tomography
(MDCT) technology has greatly improved spatial and tem-
poral solutions, which can provide a potential to assess coro-
nary atherosclerosis.5-7 Furthermore, previous studies have
demonstrated that delayed contrast-enhanced MDCT me-
thods would be a reliable technique to assess the myocardial
viability.8-10 However, increasing radiation exposure with
additional delayed contrast-enhanced computed tomo-
graphy (CT) scans is a major obstacle in assessing the
myocardial viability through delayed CT scans combined
with arterial CT scans.
More recently, new MDCT imaging protocols have been
proposed with prospective ECG-gating, in which radiation
is applied only at predefined time points of the cardiac
cycle, rather than during the entire cardiac cycle.11 To date,
the clinical application of cardiac MDCT with a prospec-
tive ECG-gating protocol in the assessment of myocardial
viability has not yet been reported. Accordingly, the pur-
poses of the present study were to compare prospective
ECG-gated 64-slice MDCT with cardiac MR imaging in
the assessment of myocardial enhancement and infarct size
early after acute reperfused myocardial infarction, and to
evaluate the stent patency after percutaneous intervention
(PCI) with stenting at the culprit lesion using prospective
ECG-gated 64-slice MDCT angiography.
Patients with reperfused myocardial infarction
Seventeen patients who were admitted with acute myocar-
dial infarction (MI) were prospectively enrolled in this
study (Table 1). MI was diagnosed on the basis of elevated
cardiac enzymes, ST-segment elevation on ECG and pre-
sence of an angiographically demonstrated partial or com-
plete occlusion of the culprit artery. All patients were suc-
cessfully treated with percutaneous coronary intervention
(PCI) with stenting.
All patients who were treated with PCI with stenting
underwent cardiac MDCT for the evaluation of stent pa-
tency and myocardial changes at the involved lesions and
cardiac MR imaging to assess the MI. Patients who had an
arrhythmia, overt heart failure, impaired renal function,
contrast allergy or any other contraindications for MR
imaging (metal implants, pacemaker or severe claustro-
phobia, etc) were excluded from this study. An explana-
tion concerning radiation risks related to CT and risks
related to CT and MR contrast media was given to each
patient. This study was undertaken after informed consent
was obtained from the patient for cardiac MDCT and MR
imaging, and the study was approved by the institutional
review boards.
CT protocols
Cardiac MDCT was performed using a 64-slice MDCT
scanner (Philips Brilliance 64, Philips Medical System,
Best, The Netherlands). With the patient in a supine posi-
tion, cardiac MDCT was performed in the craniocaudal
direction within a single breath-hold at end-inspiratory sus-
pension. A β-blocker (40 to 80 mg propranolol hydrochlo-
ride; Pranol, Dae Woong, Seoul, Korea) was administered
orally one hour before the examination to reduce the heart
rate in patients who had a heart rate of more than 70 beats
per minute. A total 2.0 mL/kg of iodinated contrast agent
(Optiray 350; Tyco healthcare, Kantata, Canada), not
exceeding a total of 150 mL, was administered using a two-
phase injection protocol on the arterial and delayed phases
of the CT images. 
Arterial phase CT imaging
We used a prospective ECG-gating protocol that involved a
step-and-shoot technique.11 The scanning parameters were
as follows: step-and-shoot axial scanning direction, 420-
msec gantry rotation time, 120 kV, 210 mAs, 64×0.625-
mm slice collimation, and 2 cm table feed per rotation.
Seventy mL of iodinated contrast medium was adminis-
tered intravenously at a rate of 5 mL/sec, followed by 40
mL of normal saline at a rate of 4 mL/sec using a power
injector (Nemoto; Nemoto Kyorindo, Tokyo, Japan). Imag-
ing was performed using a real time bolus tracking techni-
que. The scans were started 7 seconds after a trigger thre-
shold of 110 HU was reached. An ECG for each patient was
recorded simultaneously. The mean heart rate during the
scan was 61 beats per minute (BPM) (range, 56 to 67 BPM).
The image reconstruction was performed on the Brilli-
ance V2.4.5 (Philips Medical Systems, Veenpluis, The
Netherlands). The reconstruction parameters were as fol-
lows: a 0.8 mm slice thickness, a 0.45 mm increment, a 512
×512 pixels image matrix, a XCC kernel (a XCD kernel
for stent), a 15-22 cm field of view, and the center of the
imaging reconstruction window at 75% of the R-R interval.
In order to evaluate the stent patency at the culprit artery,
volume rendering technique (VRT) and curved multiplan-
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nar reformation (MPR) with 1-mm thickness were per-
formed using the Aquarius Workstation V3.6 (TeraRecon,
San Mateo, CA, USA). MPR images with a section thick-
ness of 8 mm and without a gap in a 4-chamber view and
long- and short-axis orientations of the left ventricle were
produced to assess the myocardial perfusion status.
Delayed phase CT imaging
After taking arterial phase scanning, the remaining contrast
medium was injected at a rate of 4 mL/sec, followed by 30
mL of normal saline at a rate of 4 mL/sec using a power
injector. Delayed phase scans were performed in 7 minutes
after the second bolus injection of contrast material. The
scanning protocol and image reconstruction for delayed
phase images were same as those used at the arterial phase.
MPR images with a section thickness of 8 mm and without
a gap in a 4-chamber view and long- and short-axis orien-
tations of the left ventricle were produced to assess the
myocardial perfusion status.
MR protocols
Cardiac MR imaging was performed with a 1.5T system
(Magnetom Avanto; Siemens Medical Solutions, Erlan-
gen, Germany). After completion of the perfusion images
with a bolus injection of 0.1 mmol/kg gadopentetate dimegl-
umine (Magnevist; Schering, Berlin, Germany) at the rate
of 4 mL, followed by 20 ml of normal saline at the rate of
4 mL/sec using a power injector (Nemoto; Nemoto Kyo-
rindo, Tokyo, Japan), cine images were obtained for the
assessment of myocardial contractile function and wall
motion (not included for data analysis in this study).  
Delayed phase MR imaging
A second bolus of 0.1 mmol/kg of gadopentetate dimeglu-
mine was intravenously administered at the rate of 4 mL
followed by 20 mL of normal saline at a rate of 4 mL/sec
using a power injector. We performed gradient echo se-
quences with varying inversion times in order to select the
most appropriate inversion time to null the signal from the
normal myocardium. Imaging parameters were as follows:
repetition time/echo time, 23.5/1.1 msec; image matrix, 19
×78; flip angle, 25O; inversion pulse, 180O; and inversion
time, 150-650 msec. 
Ten minutes after the administration of a second bolus
of gadopentetate dimeglumine (total, 0.2 mmol/kg), delay-
ed enhancement images were obtained in a 4-chamber
view and long- and short-axis orientations of the left ven-
tricle with 8-mm section thickness using inversion reco-
very prepared turbo gradient echo sequence. The image
parameters were as follows: repetition time/echo time,
variable/variable; image matrix 256×156; echo train
length, 1; flip angle, 25O; pixel bandwidth 130 kHz; section
thickness, 8 mm; and inversion time, 180-380 ms. 
Data analysis
The image sets were transferred to separate workstations
for cardiac MDCT (Aquarius Workstation V3.6; TeraRe-
con, San Mateo, CA, USA) and MR (Syngo Numaris/4;
Siemens Medical Solutions, Erlangen, Germany) for anal-
ysis. The dose-length product displayed by the CT unit was
recorded at the arterial and delayed enhancement phases
for each cardiac CT examination. The effective dose was
calculated by multiplying the dose-length product by the
conversion coefficient (0.017) for the chest and expressed
as millisieverts.12
We assessed CT images on the first analysis session and
then evaluated MR images in 1 month after evaluation of
CT images. On the arterial phase of CT images, the stent
patency was evaluated in consensus by two readers. The
stent was regarded to be patent if the lumen was filled with
contrast material without filling defect and if the distal seg-
ment of the vessel was well traced on the CPR images.
Two independent readers then evaluated the values of
attenuation or signal intensity and the size of the perfusion
deficit or infarct myocardium on the CT and MR images.
We measured the values of CT attenuation and MR signal
intensity for each technique by drawing regions of interest
of approximately 30 mm2 in areas of hypo- or hyperen-
hanced and remote normal myocardium on the arterial and
delayed phases of CT images and on the delayed phase of
MR images. The mean values measured by two readers
were used for evaluation of the contrast-to-noise ratio
(CNR) between the infarct and remote normal myocar-
dium. The CNR was calculated as the attenuation dif-
ference in CT or the signal intensity difference in MR imag-
ing between the infarct and remote normal myocardium,
divided by the standard deviation of the CT attenuation or
MR signal intensity within the remote normal myocard-
ium.
The total size of the perfusion defect or infarct, which
was expressed as a percentage of the total left ventricular
myocardial mass, was evaluated by two observers who
were blind to the clinical history on the arterial and delayed
phases of CT images and on the delayed phase of MR
images. Arterial phase CT images were assessed using pre-
defined image display setting: window width, 200 HU;
window level, 100 HU. For delayed enhancement CT, the
window level was set at 100 HU, and the width was set at
150 HU.
Statistical analysis
Continuous variables are presented as means ± standard
deviations. The statistical differences for the CNR were
examined using a Student t-test between the arterial and
delayed phases of CT images and between the delayed
phase images of CT and those of MR imaging. A Pear-
son’s correlation and Bland-Altman analysis13 were per-
formed to determine the correlation and limits of agreement
for infarct sizes between the arterial and delayed phases of
CT images and between the delayed phase images of CT
and those of MR imaging. A p value of less than 0.05 was
considered significant. SPSS software (version 12.0.1,
Statistical Package for the Social Sciences, Chicago, IL,
USA) was used for the statistical evaluations. Inter-obser-
ver variability (Var) for the infarct size measured by the
delayed phase images of CT and MR imaging was assess-
ed with two-way random, single-measure intra-class
correlation coefficient (ICC).
Radiation dose and stent patency
The mean longitudinal length for prospective gating was
13.1 ± 1.4 cm (range 12.3-15.5 cm) on the arterial phase of
CT images and 12.6 ± 0.8 cm (range 12.4-15.5 cm) on the
delayed enhanced phase of CT images. Mean patient
radiation dose was 3.9 ± 0.5 mSv (range, 3.5-4.6 mSv) on
the arterial phase of CT images and 3.8 ± 0.3 mSv (range,
3.6-4.7 mSv) on the delayed enhanced phase of CT images.
Total mean radiation dose was 7.7 ± 0.5 mSv (range, 7.2-
8.5 mSv) on the arterial and delayed enhanced phases of
CT images.
A total of 19 stents in 17 patients were evaluated. Of
these, 12 had a beam hardening artifact without motion
artifact, while 6 had a beam hardening artifact with mild
motion artifact that did not limit lumen evaluation (2 in
RCA, 3 in LAD, and 1 in LCx) (Figs. 1A-C and 2A-C). One
stent demonstrated a severe artifact due to a beam harden-
ing artifact and coronary artery motion, which would be an
obstacle in evaluating luminal patency (1 in RCA).
Comparison between arterial and delayed phases of 
cardiac CT imaging
On the arterial phase of CT images, areas of hypoenhan-
cement were visualized in 14 of 17 patients. Areas of del-
ayed hyperenhancement were observed in all 17 patients
on the delayed phase of CT images (Figs. 1D-F and  2D-I).
Mean CT attenuation on the arterial phase of the CT images
was 65 ± 19 Hounsfield Units (HU) in infarct myocardium
and 104 ± 17 HU in normal myocardium. Mean CT atten-
uation on the delayed phase of CT images was 125 ± 23
HU in infarct myocardium and 89 ± 16 HU in normal
myocardium. Delayed phase of CT images had a better
CNR than arterial phase of CT images (4.3 ± 2.1% vs. 2.3
± 1.7%, p < 0.01) (Table 2). 
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Table 1. Characteristics of 17 Patients with Myocardial Infarction
Characteristic Data
Age (yrs)* 61 ± 11 (42 - 78)
Sex 11 male / 6 female
Risk profile
Diabetes 5
Hypertension 7
Smoking 9
History of coronary disease 1
Infarct-related artery
Right coronary artery 4
Left anterior descending coronary artery 11
Left circumflex coronary artery 2
Stenosis
Total (100%) 14
Subtotal (< 99%) 3
Interval onset MI-PCI (hrs) 4.8 (3 - 15)
Mean diameter of stent (mm) 3.6 (3.0 - 4.5)
Interval PCI-CT (days) 5.6 (4 - 8)
Interval CT-MR 1.2 (0 - 3)
Peak creatine phosphokinase level (µg/mL)* 2,275 ± 2,333 (412 - 7,834)
Peak troponin T level (µg/mL)* 10 ± 12 (0.11 - 33.5)
MI, myocardial infarct; PCI, percutaneous coronary intervention; CT, computed tomography; MR, magnetic resonance. 
*Data are means ± standard deviations, with ranges in parentheses.
The mean area of hypoenhanced myocardium was 15  ±
10% (range, 0-34%) on the arterial phase of CT images
and the mean area of hyperenhanced myocardium was 20
± 10% (range, 4-38%) on the delayed phase of CT images.
There was good correlation between the mean area of
hypoenhanced myocardium on the arterial phase of CT
images and the mean area of hyperenhanced myocardium
on the delayed phases of CT images (Y = 6.296 + 0.928 X,
r = 0.911, p = 0.001) with a mean difference of 5.2 ± 8.5%
(p = 0.001) (Fig. 3) (Table 3).
Comparison between delayed cardiac MDCT and MR
imaging
Delayed hyperenhanced areas were observed in all 17 pati-
ents on the delayed enhancement MDCT and MR imaging
(Figs. 1E, F and 2E, F, H, I). Mean signal intensity on the
delayed phase of MR images was 86 ± 30 arbitrary units
(AU) in infarct myocardium and 14 ± 10 AU in normal
myocardium. Delayed MR images had a better CNR than
delayed phase of CT images (27.1 ± 17.8% vs. 4.3 ± 2.1%,
p < 0.001) (Table 2).
The mean area of hyperenhanced myocardium was 22 ±
10% (range, 4-36%) on the delayed MR images. There
was good correlation between the mean area of hyperen-
hanced myocardium on the delayed phase of CT images
and that of hyperenhanced myocardium on the delayed
MR images (Y = 3.209 + 0.919 X, r = 0.935, p = 0.001)
with a mean difference of 1.6 ± 7.3% (p = 0.10) (Fig. 4)
(Table 3).
Interobserver agreement
Interobserver agreements for measurements of infarct size
represented by the hyperenhancement area were ICC =
0.94 and ICC = 0.91 on the delayed enhanced CT and MR
images, respectively.
The major findings of the present study were that delayed
MDCT images could show the myocardial infarct as a
hyperenhanced area that was well correlated to the area
measured by delayed cardiac MR imaging. Furthermore,
arterial MDCT images could show the stent patency after
doing PCI with stenting in patients with myocardial infarc-
tion. The total mean radiation dose, including the arterial
and delayed phases of CT images, was below 8 mSv, which
is clinically acceptable. However, a CNR was not good in
Reperfused Myocardial Infarction with MDCT and MRI
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A B C
D E F
Fig. 1. Images obtained for a 50-year-old man with anterolateral myocardial infarction. (A) Total occlusion in the ramus intermedius (RI) (arrow) and
60% stenosis in the mid-LAD artery. (B and C) Patent stents at the culprit lesion of RI and the LAD artery on 3D-VRT (A) and curved MPR (C) CT
images after PCI with stenting. (D-F) No definite area of hypoperfusion and some beam-hardening artifact in anterior and posterior wall of left
ventricle on the arterial CT image (D), anterolateral hyperenhancement on delayed phase CT (E) (white arrows) and MR (F) images. LAD, left
anterior descending artery; 3D-VRT, 3 dimensional volume rendering technique; MPR, multiplannar reformatted imaged; CT, computed
tomography; PCI, percutaneous coronary intervention. LAD, left anterior descending artery; 3D-VRT, 3-dimensional volume rendering technique;
MPR, multiplannar reformatted imaged; CT, computed tomography; PCI, percutaneous coronary intervention; MR, magnetic resonance.
the delayed phase of CT images when compared to the
delayed MR images.
Cardiac MDCT has recently emerged as the promising
diagnostic tool for infarct characterization, based on experi-
mental studies in animals2,14-16 as well as by clinical studies
in patients.10,17 The main problem in evaluating myocardial
infarction using cardiac MDCT is radiation exposure. For
64-slice MDCT coronary angiography, dose values of up
to 15.2 mSv for males and 21.4 mSv for females have
been reported.6 The radiation exposure can, however, be
reduced by technical adjustments such as ECG-dependent
tube current modulation. This technique reduces the radia-
tion exposure up to 47%, depending on the patient’s heart
rate.18 However, ECG-gating technique in cardiac CT
Hye Mi Gweon, et al.
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Fig. 2. Images obtained for a 59-year-old man with anteroseptal myocardial infarction. (A) Total occlusion at ostium of the LAD artery (arrowhead).
(B and C) A patent stent at the culprit lesion of LAD artery on 3D-VRT (B) and curved MPR (C) CT images after PCI with stenting. (D-I) Anteroseptal
hypoperfusion on early arterial CT images (D-G) (arrows), anteroseptal hyperenhancement on delayed phase CT (E-H) (arrows) and MR (F-I)
images. LAD, left anterior descending artery; 3D-VRT, 3-dimensional volume rendering technique; MPR, multiplannar reformatted imaged; CT,
computed tomography; PCI, percutaneous coronary intervention; MR, magnetic resonance.
Table 2. Contrast-to-Noise Ratio of Cardiac CT and MR Imaging in 17 Patients with Myocardial Infarct
Model Phase Normal Infarct CNR p value
MDCT
Arterial 104 ± 17 65 ± 19 2.3 ± 1.7 0.01
Delayed 89 ± 16 125 ± 23 4.3 ± 2.1 0.01
MRI Delayed 14 ± 10 86 ± 30 27.1 ± 17.8 0.001
CNR, contrast-to-noise ratio; MDCT, multi-detector row computed tomography; MRI, magnetic resonance imaging.
Data are means ± standard deviations.
imaging is still limited due to the repeated exposure to radia-
tion necessary to acquire the arterial and delayed phases of
CT images. 
More recently, a new MDCT imaging protocol has been
proposed with a prospective ECG-gating technique that
limits radiation exposure to only predefined time points in
the cardiac cycle, rather than during the entire cardiac
cycle.11 Hirai, et al.19 reported that the calculated effective
dose with prospective CT angiography was 79% lower
than that with retrospective CT angiography. Although, the
reduction in radiation exposure was not compared between
prospective and retrospective ECG-gating techniques in
our study, the former technique showed a mean effective
dose of about 7.7 mSv during the combined studies of the
arterial and delayed phases of CT images. 
The advantages of a two-phase CT study are that the
arterial phase of CT images can provide information of
early perfusion status of the myocardium as well as infor-
Reperfused Myocardial Infarction with MDCT and MRI
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A B
Fig. 3. Linear regression analysis and Bland-Altman plots for infarct size between early arterial and delayed phase MDCT images. (A) Areas of
hypoperfusion and hyperenhancement for early arterial phase and delayed phase MDCT images (Y = 6.296 + 0.928X, r = 0.911, p < 0.001). (B) Bland-
Altman plots showing the relationship between early arterial MDCT images and delayed enhanced MDCT images. Mean differences (y-axes)
between each pair [(mean MDCTd) - (mean MDCTa)] are plotted against the average values (x-axes) of the same pair [{(mean MDCTd) + (mean
MDCTa)}/2]. These results showed that area of hyperenhancement on the delayed phase MDCT images was 5.2% larger than that of
hypoenhancement on the arterial phase MDCT images (p < 0.05). MDCTd (a) = multidetector computed tomography, arterial phase (delayed
phase). MDCT, multidetector computed tomography.
A B
Fig. 4. Linear regression analysis and Bland-Altman plots for infarct size between delayed phase MDCT images and delayed phase MR images.
(A) Areas of hyperenhancement for delayed phase MDCT and MR images (Y = 3.209 + 0.919X, r = 0.935, p < 0.001). (B) Bland-Altman plots showing
the relationships between delayed enhanced MDCT and MR images. Mean differences (y-axes) between each pair [(mean MRId) - (mean
MDCTd)] are plotted against the average values (x-axes) of the same pair [{(mean MRId) + (mean MDCTd)}/2]. These results showed that the
delayed phase MDCT infarct size was 1.6% larger than MRI (p = 0.10).  MDCT, multidetector computed tomography.
Table 3. Mean Sizes of Hypo- or Hyperenhanced Areas on the Cardiac CT and MR Images for 17 Patients 
with Myocardial Infarct
Model Hypo- (%) / Arterial Hyper- (%) / Delayed p value
MDCT 15 ± 10 20 ± 10 0.001
MRI - 22 ± 10 -
p value - 0.10
Hypo- or Hyper-, hypoenhanced or hyperenhanced areas on arterial or delayed CT images; MDCT, multi-detector row computed 
tomography; MRI, magnetic resonance imaging. 
Data are means ± standard deviations. 
mation of the stent patency just after PCI with stenting in
patients with myocardial infarction. In our study, the arterial
phase of CT images showed good patency of the stent in
most patients except a patient who has poor image quality
of the stent due to severe motion artifact. The motion arti-
fact is usually more severe in the right coronary artery.20,21
We also experienced more severe motion artifacts in the
right coronary artery than in the left coronary artery, al-
though we maintained a heart rate below 65 beats per
minute. The motion artifact seemed to be caused by the
limit in temporal resolution in our CT scanner, which had
420 msec of tube rotation time. Delayed CT imaging with
prospective gating technique can effectively reveal myo-
cardial infarction as a hyperenhanced area in spite of the
relatively lower radiation exposure of about 3.8 mSv. The
volume of myocardial infarction on the delayed CT images
was well correlated with that on the delayed MR images,
but there was no clinically significant difference between
the two modalities. 
Limitations
Our study has some limitations that should be overcome in
the future. First, the study population was too small to
generalize the results in all patients without arrhythmia.
Second, there was no comparative study for evaluation of
stent patency using the arterial phase of CT images. Third,
we did not optimize the proper delay time for late enhanced
CT images. The previous reports have suggested intervals
ranging from 5 to 15 minutes after administration of con-
trast medium, which is similar to intervals used in MR
imaging.2 However, dedicated injection protocols should
be developed to optimize the contrast-to-noise ratio accord-
ing to the amount of contrast media. Forth, we did not
evaluate the presence of the hypoenhanced area within
myocardial infarction, which is known to be the area of
microvascular obstruction or no-reflow on the delayed
phase CT or MR imaging. Finally, we did not consider
manipulation of the kVp to reduce the radiation dose accord-
ing to the patient’s body weight. It may be possible to
reduce the effective radiation exposure more effectively if
we control the kVp according to the body mass index of
patients in the future study.
Conclusion
The present study demonstrates that the delayed phase of
CT imaging can depict a myocardial infarction as an area
of increased attenuation values, which is similar to the pat-
tern of myocardial enhancement on delayed MR images.
The arterial CT images can be used to show the perfusion
status, which has lower attenuation values in the infarct
area, as well as to assess the stent patency in patients with
PCI with stenting after myocardial infarction.
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